Baupost Group
13F Holdings and Portfolio Analysis
Seth Klarman 2014 Q3 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Baupost Group Overview
Baupost Group held 27 stocks in 2014 Q3, with total market value around $5.74B.
Baupost Group's top five holdings in 2014 Q3: Micron Technology, Inc.(MU) 30.82%, CHENIERE ENERGY INC 15.61%, VIASAT INC(VSAT) 11.07%, EBAY INC. COM(EBAY) 6.01%, THERAVANCE INC 5.90%.
- Portfolio Value
- $5.74B
- Current Holdings
- 27 stocks
- New / Increased
- 4 / 6
- Reduced / Exited
- 3 / 1
Current Holdings
| 1 | Micron Technology, Inc.MU | 1.77 | 30.82% | 51.66 - | $34.26 | $971.00 +2734.21% | $15.43 | 0.00 | 1.50 | +$49.36B+6191.47% | Held |
| 2 | CHENIERE ENERGY INCCUSIP 16411R208 | 0.90 | 15.61% | 11.20 +87.03% | $80.03 | - | $67.31 | +5.21 | 0.75 | +$0.14B+18.89% | Increased |
| 3 | VIASAT INCVSAT | 0.64 | 11.07% | 11.53 - | $55.12 | - | $71.14 | 0.00 | 1.50 | -$0.18B-22.52% | Held |
| 4 | EBAY INC. COMEBAY | 0.35 | 6.01% | 6.10 +37.43% | $56.63 | - | $51.85 | +1.66 | 0.50 | +$0.03B+9.22% | Increased |
| 5 | THERAVANCE INCCUSIP 88338T104 | 0.34 | 5.90% | 19.82 -2.84% | $17.09 | - | $38.32 | -0.58 | 1.50 | -$0.42B-55.40% | Reduced |
| 6 | KERYX BIOPHARMACEUTICALS INCCUSIP 492515101 | 0.25 | 4.38% | 18.30 +73.62% | $13.75 | - | $15.26 | +7.76 | 0.75 | -$0.03B-9.90% | Increased |
| 7 | OCWEN FINANCIAL CORP COMMON STOCKCUSIP 675746309 | 0.18 | 3.19% | 7.00 | $26.18 | - | $26.18 | +7.00 | 0.25 | $0.00B0.00% | New |
| 8 | PBF ENERGY INCCUSIP 69318G106 | 0.17 | 2.99% | 7.15 +27.70% | $24.00 | - | $25.79 | +1.55 | 1.25 | -$0.01B-6.95% | Increased |
| 9 | ANTERO RES CORPCUSIP 03674X106 | 0.15 | 2.64% | 2.76 | $54.89 | - | $54.89 | +2.76 | 0.25 | $0.00B0.00% | New |
| 10 | THERAVANCE BIOPHARMA INCCUSIP G8807B106 | 0.14 | 2.43% | 6.06 - | $23.05 | - | $31.88 | 0.00 | 0.50 | -$0.05B-27.70% | Held |
| 11 | VERITIV CORPCUSIP 923454102 | 0.12 | 2.06% | 2.36 | $50.06 | - | $50.06 | +2.36 | 0.25 | $0.00B0.00% | New |
| 12 | CITIGROUP INCCUSIP 172967226 | 0.12 | 2.03% | 122.57 - | $0.95 | - | $0.75 | 0.00 | 1.50 | +$0.02B+26.90% | Held |
| 13 | RF MICRODEVICES INCCUSIP 749941100 | 0.11 | 1.96% | 9.76 - | $11.54 | - | $8.44 | 0.00 | 0.75 | +$0.03B+36.79% | Held |
| 14 | TRIQUINT SEMICONDUCTOR INCCUSIP 89674K103 | 0.11 | 1.95% | 5.88 - | $19.07 | - | $14.24 | 0.00 | 0.75 | +$0.03B+33.96% | Held |
| 15 | SUNEDISON SEMICONDUCTOR LTDCUSIP Y8213L102 | 0.08 | 1.40% | 4.15 - | $19.35 | - | $16.93 | 0.00 | 0.50 | +$0.01B+14.29% | Held |
| 16 | CHIPMOS TECH BERMUDA LTDCUSIP G2110R114 | 0.07 | 1.29% | 3.28 - | $22.62 | - | $19.13 | 0.00 | 1.50 | +$0.01B+18.22% | Held |
| 17 | NOVAGOLD RES INCCUSIP 66987E206 | 0.07 | 1.14% | 21.69 - | $3.03 | - | $2.11 | 0.00 | 1.50 | +$0.02B+43.60% | Held |
| 18 | KOSMOS ENERGY LTDCUSIP G5315B107 | 0.05 | 0.82% | 4.75 - | $9.96 | - | $11.23 | 0.00 | 0.50 | -$0.01B-11.31% | Held |
| 19 | SYNERON MEDICAL LTDCUSIP M87245102 | 0.03 | 0.52% | 2.99 -25.13% | $10.02 | - | $8.70 | -1.01 | 1.50 | +$0.00B+15.17% | Reduced |
| 20 | KINDRED BIOSCIENCES INCCUSIP 494577109 | 0.03 | 0.49% | 3.01 +9.05% | $9.25 | - | $11.01 | +0.25 | 1.00 | -$0.01B-15.99% | Increased |
| 21 | AMERICAN INTL GROUP INCCUSIP 026874156 | 0.02 | 0.33% | 0.79 - | $23.80 | - | $19.64 | 0.00 | 1.50 | +$0.00B+21.17% | Held |
| 22 | THERAVANCE INC CV SUB NTCUSIP 88338TAB0可转换债券 | 0.02 | 0.29% | 17.09 | $0.96 | - | $0.96 | +17.09 | 0.25 | $0.00B0.00% | New |
| 23 | ALLIANCE ONE INTL INCCUSIP 018772103 | 0.01 | 0.22% | 6.38 - | $1.97 | - | $3.80 | 0.00 | 1.50 | -$0.01B-48.16% | Held |
| 24 | BOYD GAMING CORPCUSIP 103304101 | 0.01 | 0.17% | 0.98 -64.95% | $10.16 | - | $12.13 | -1.82 | 0.50 | -$0.00B-16.24% | Reduced |
| 25 | ALON USA PARTNERS LPCUSIP 02052T109 | 0.01 | 0.10% | 0.33 - | $17.71 | - | $16.66 | 0.00 | 1.00 | +$0.00B+6.31% | Held |
Showing 1-25 of 27
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2014 Q3.
| 1 | IDENIX PHARMACEUTICALS INCCUSIP 45166R204 | 53.33 | 1.25 | $4.65 | $23.81 | +$1.02B+411.41% |
Showing 1-1 of 1
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.